NCT04083547CompletedNot Applicable
Cirkulerande Tumörceller Hos Patienter Med Bukhinnespridda tumörer
Uppsala University1 site in 1 country114 target enrollmentStarted: October 17, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 114
- Locations
- 1
- Primary Endpoint
- Prognostic value
Study Overview
Brief Summary
This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.
Detailed Description
CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Peritoneal metastases being treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Prognostic value
Time Frame: 2 year.
Prediction of survival and recurrence according to the occurrence of CTCs.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone TherapyPatients With High-risk Prostate CancerNCT01800058Fundación de Investigación Biomédica - Hospital Universitario de La Princesa68
Completed
Not Applicable
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerProstate CancerNCT05533515Queen Mary University of London330
Completed
Phase 3
Circulating Tumor Cells (CTCs) A prognostic biomarker in Patients with Hepatocellular CarcinomaCirculating tumor cells, liquid biopsy, hepatocellular carcinoma, biomarkerHepatocellular carcinomaTCTR20211226001/A73
Completed
Not Applicable
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC PatientsNasopharyngeal NeoplasmsNCT02505139Sun Yat-sen University166
Completed
Not Applicable
The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced DiseaseBladder CancerNCT00829920University of Colorado, Denver44